John Piede in Bessemer, Alabama

Home Alabama Bessemer

John Piede has Medical Oncology as his primary medical specialty. Their primary office is: 737 Memorial Dr in Bessemer, Alabama. There are 2 additional office locations for John Piede that can be viewed towards the end of their profile.

They're a part of the: Birmingham Hematology Oncology Assoc Llc medical group which has around 28 members. You can call their office at 205-481-4511 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Medical College Of Georgia School Of Medicine and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

John A Piede Office Phone and Directions

John Piede
Birmingham Hematology Oncology Assoc Llc
737 Memorial Dr
Bessemer, Alabama 35022
205-481-4511

Patient Ratings
Please rate your experience with John Piede below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 205-481-4511

Enter a starting address:

Healthcare Info for John Piede

Medical School: Medical College Of Georgia School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for John Piede is listed as: Medical Oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 3971654427
NPI #: 1972782548
NPI Created On: 10/30/2007
NPI Last Updated Listed as: 12/18/2018
Primary Taxonomy Code: 207RH0003X
License Number:
32392
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882587

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882601

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788882603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Additional Office Locations

1. Birmingham Hematology Oncology Assoc Llc
2728 10th S Ave
Birmingham, AL 35205
Suite 200
Group Members: 28

Phone: 205-481-4511

Enter a starting address:

2. Birmingham Hematology Oncology Assoc Llc
810 Saint Vincents Dr
Birmingham, AL 35205
Group Members: 28

Phone: 205-481-4511

Enter a starting address:

Medical Oncology Professionals in Bessemer

1.
Katisha Vance MD

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

2.
Ashley Fry

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

3.
Christopher Wang

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

4.
Stephen Beck

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

5.
Shaily Lakhanpal

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

6.
Benjamin Jones

737 Memorial Dr
Bessemer, AL
Birmingham Hematology Oncology Assoc Llc

Providers in Birmingham Hematology Oncology Assoc Llc

1.Brian Adler Md

2022 Brookwood Med Ctr
Birmingham Al 35213-1966
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

2.Daniel Allendorf

1024 1st St N
Alabaster Al 35007-8703
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

3.Stephen Beck

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

4.Stephen Beck

2728 10th S Ave
Birmingham Al 35205-1202
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

5.Stephen Beck

810 Saint Vincents Dr
Birmingham Al 35205-1601
Birmingham Hematology Oncology Assoc Llc
Medical Oncology

6.Cara Bondly Md

737 Memorial Dr
Bessemer Al 35022-6029
Birmingham Hematology Oncology Assoc Llc
Hematology/oncology

View all 28 members of Birmingham Hematology Oncology Assoc Llc medical group